SEER Q4 2020 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$98M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$336,000+479.3% YoY

Gross Profit

-$138,000-41.1% margin

Operating Income

-$13M-3881.3% margin

Net Income

-$13M-3850.0% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$6M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$442M

Total Liabilities

$11M

Stockholders' Equity

$432M

Cash & Equivalents

$334M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$336,000	$58,000	+479.3%
Gross Profit	-$138,000	-$150,000	+8.0%
Operating Income	-$13M	-$5M	-141.6%
Net Income	-$13M	-$5M	-151.4%